Sihuan Pharmaceutical Holdings Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG8162K1137
HKD
1.31
0.02 (1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Zhongzhi Pharmaceutical Holdings Ltd.
China Shineway Pharmaceutical Group Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd.
CK Life Sciences International (Holdings), Inc.
HBM Holdings Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Wai Yuen Tong Medicine Holdings Ltd.
PuraPharm Corp. Ltd.
Hin Sang Group (International) Holding Co. Ltd.
China Health Group, Inc.
Why is Sihuan Pharmaceutical Holdings Group Ltd. ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 84.51%, its profits have fallen by -20.7%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sihuan Pharmaceutical Holdings Group Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sihuan Pharmaceutical Holdings Group Ltd.
84.51%
2.73
55.60%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.18%
EBIT Growth (5y)
-193.65%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.33
Tax Ratio
10.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.59%
ROE (avg)
1.99%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.93
EV to EBIT
-23.79
EV to EBITDA
-60.16
EV to Capital Employed
6.77
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
0.68%
ROCE (Latest)
-28.46%
ROE (Latest)
-11.07%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Sihuan Pharmaceutical Holdings Group Ltd.
Inventory Turnover Ratio
Highest at 1.11%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by 1.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At HKD 138.95 MM has Grown at 8.23%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Sihuan Pharmaceutical Holdings Group Ltd.
Operating Cash Flow
Lowest at HKD 707.83 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Interest
Highest at HKD 154.55 MM
in the last five periods and Increased by 7.68% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Pre-Tax Profit
Fallen at -55.35%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Cash and Eqv
Lowest at HKD 4,125.29 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -66.32 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio